Quick Answer
GoodRx Holdings, Inc. reported Total Assets of $1.40 billion for the year ending 2025.
- GoodRx Holdings, Inc. showed an increase of +1.2% in Total Assets from 2024 to 2025.
- This data is from GoodRx Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $1.55 billion | Q1 2021: $1.51 billion | Q2 2021: $1.59 billion | Q3 2021: $1.61 billion | Q1 2022: $1.54 billion | Q2 2022: $1.59 billion | Q3 2022: $1.57 billion | Q1 2023: $1.61 billion | Q2 2023: $1.69 billion | Q3 2023: $1.71 billion | Q1 2024: $1.45 billion | Q2 2024: $1.48 billion | Q3 2024: $1.35 billion | Q1 2025: $1.30 billion | Q2 2025: $1.32 billion | Q3 2025: $1.33 billion.
- Over the full 7 years of available data (2019 to 2025), GoodRx Holdings, Inc.'s Total Assets has grown by 263.0%.
- Historical annual values: Fiscal year 2025: $1.40 billion | Fiscal year 2024: $1.39 billion | Fiscal year 2023: $1.59 billion | Fiscal year 2022: $1.60 billion | Fiscal year 2021: $1.61 billion | Fiscal year 2020: $1.47 billion | Fiscal year 2019: $386.80 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: